nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—MPO—Dapsone—systemic lupus erythematosus	0.421	1	CbGbCtD
Octreotide—SSTR4—nervous system—systemic lupus erythematosus	0.00649	0.0902	CbGeAlD
Octreotide—SSTR4—central nervous system—systemic lupus erythematosus	0.00625	0.0868	CbGeAlD
Octreotide—SSTR2—kidney—systemic lupus erythematosus	0.00542	0.0753	CbGeAlD
Octreotide—SSTR3—nervous system—systemic lupus erythematosus	0.00529	0.0735	CbGeAlD
Octreotide—MPO—endothelium—systemic lupus erythematosus	0.0051	0.0708	CbGeAlD
Octreotide—SSTR3—central nervous system—systemic lupus erythematosus	0.0051	0.0708	CbGeAlD
Octreotide—MPO—blood plasma—systemic lupus erythematosus	0.00453	0.0629	CbGeAlD
Octreotide—SSTR1—lung—systemic lupus erythematosus	0.00452	0.0627	CbGeAlD
Octreotide—SSTR1—nervous system—systemic lupus erythematosus	0.00418	0.0581	CbGeAlD
Octreotide—SSTR1—central nervous system—systemic lupus erythematosus	0.00403	0.0559	CbGeAlD
Octreotide—SSTR2—nervous system—systemic lupus erythematosus	0.00356	0.0494	CbGeAlD
Octreotide—SSTR2—central nervous system—systemic lupus erythematosus	0.00343	0.0476	CbGeAlD
Octreotide—MPO—connective tissue—systemic lupus erythematosus	0.00241	0.0335	CbGeAlD
Octreotide—MPO—skin of body—systemic lupus erythematosus	0.00218	0.0302	CbGeAlD
Octreotide—MPO—kidney—systemic lupus erythematosus	0.00205	0.0285	CbGeAlD
Octreotide—MPO—lymphoid tissue—systemic lupus erythematosus	0.00176	0.0245	CbGeAlD
Octreotide—MPO—bone marrow—systemic lupus erythematosus	0.00161	0.0223	CbGeAlD
Octreotide—MPO—lung—systemic lupus erythematosus	0.00145	0.0202	CbGeAlD
Octreotide—MPO—nervous system—systemic lupus erythematosus	0.00135	0.0187	CbGeAlD
Octreotide—MPO—central nervous system—systemic lupus erythematosus	0.0013	0.018	CbGeAlD
Octreotide—SSTR4—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000268	0.00178	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—F2—systemic lupus erythematosus	0.000265	0.00176	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000264	0.00175	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000262	0.00174	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—C3—systemic lupus erythematosus	0.000256	0.0017	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000254	0.00169	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—F2—systemic lupus erythematosus	0.000254	0.00169	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000253	0.00168	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—IL6—systemic lupus erythematosus	0.000251	0.00167	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	0.000247	0.00164	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CSK—systemic lupus erythematosus	0.000246	0.00164	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000244	0.00162	CbGpPWpGaD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000243	0.00162	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000243	0.00161	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000242	0.00161	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000237	0.00158	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—C3—systemic lupus erythematosus	0.000237	0.00157	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000236	0.00157	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	0.000234	0.00155	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000231	0.00154	CbGpPWpGaD
Octreotide—SSTR1—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	0.00023	0.00153	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.00023	0.00153	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000228	0.00151	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000227	0.00151	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000226	0.0015	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000225	0.0015	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—F2—systemic lupus erythematosus	0.000225	0.0015	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000225	0.00149	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—LYN—systemic lupus erythematosus	0.000224	0.00149	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000222	0.00147	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000221	0.00147	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.00022	0.00146	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000216	0.00144	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000216	0.00143	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000209	0.00139	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000209	0.00139	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—F2—systemic lupus erythematosus	0.000208	0.00138	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000207	0.00137	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000206	0.00137	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—C3—systemic lupus erythematosus	0.000204	0.00136	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000203	0.00135	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000202	0.00134	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000201	0.00133	CbGpPWpGaD
Octreotide—SSTR5—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000201	0.00133	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.0002	0.00133	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	0.0002	0.00133	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000197	0.00131	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000196	0.00131	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000194	0.00129	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000192	0.00127	CbGpPWpGaD
Octreotide—SSTR2—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	0.000189	0.00125	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CSK—systemic lupus erythematosus	0.000187	0.00124	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000186	0.00124	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000185	0.00123	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000184	0.00122	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000184	0.00122	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000183	0.00122	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000181	0.0012	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.00018	0.0012	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—F2—systemic lupus erythematosus	0.000179	0.00119	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CSK—systemic lupus erythematosus	0.000179	0.00119	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000178	0.00118	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000177	0.00117	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000176	0.00117	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000174	0.00116	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000172	0.00115	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000172	0.00114	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000171	0.00113	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—C3—systemic lupus erythematosus	0.00017	0.00113	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LYN—systemic lupus erythematosus	0.00017	0.00113	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000169	0.00112	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000168	0.00112	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000167	0.00111	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000167	0.00111	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000166	0.00111	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000165	0.00109	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000164	0.00109	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000164	0.00109	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000163	0.00109	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.000163	0.00108	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—PRL—systemic lupus erythematosus	0.000163	0.00108	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LYN—systemic lupus erythematosus	0.000163	0.00108	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.00016	0.00106	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.00016	0.00106	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.00016	0.00106	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000159	0.00106	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CSK—systemic lupus erythematosus	0.000159	0.00105	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000158	0.00105	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000157	0.00104	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000156	0.00104	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—C3—systemic lupus erythematosus	0.000155	0.00103	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000152	0.00101	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.00015	0.000999	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.00015	0.000994	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—F2—systemic lupus erythematosus	0.00015	0.000994	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—C3—systemic lupus erythematosus	0.000148	0.000986	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000148	0.000985	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CSK—systemic lupus erythematosus	0.000147	0.000973	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000146	0.000971	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000145	0.000965	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000145	0.000964	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000145	0.000963	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.000144	0.000959	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LYN—systemic lupus erythematosus	0.000144	0.000958	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000143	0.000953	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000142	0.000944	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000141	0.00094	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.000137	0.000909	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000137	0.000907	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—F2—systemic lupus erythematosus	0.000136	0.000903	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.000135	0.000896	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000135	0.000895	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000134	0.00089	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NCF2—systemic lupus erythematosus	0.000134	0.00089	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—C3—systemic lupus erythematosus	0.000134	0.000889	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LYN—systemic lupus erythematosus	0.000133	0.000884	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000133	0.000883	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000133	0.000882	CbGpPWpGaD
Octreotide—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000132	0.00037	CcSEcCtD
Octreotide—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000132	0.00037	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—C3—systemic lupus erythematosus	0.000132	0.000874	CbGpPWpGaD
Octreotide—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000132	0.000369	CcSEcCtD
Octreotide—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000132	0.000369	CcSEcCtD
Octreotide—Nausea—Leflunomide—systemic lupus erythematosus	0.000131	0.000369	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.000131	0.000871	CbGpPWpGaD
Octreotide—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000131	0.000367	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000131	0.000869	CbGpPWpGaD
Octreotide—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000131	0.000367	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.000131	0.000867	CbGpPWpGaD
Octreotide—Vision blurred—Prednisone—systemic lupus erythematosus	0.00013	0.000366	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—JAK1—systemic lupus erythematosus	0.00013	0.000866	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—F2—systemic lupus erythematosus	0.00013	0.000865	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.00013	0.000365	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.00013	0.000364	CcSEcCtD
Octreotide—Pain—Hydrocortisone—systemic lupus erythematosus	0.00013	0.000364	CcSEcCtD
Octreotide—Oedema—Dexamethasone—systemic lupus erythematosus	0.00013	0.000364	CcSEcCtD
Octreotide—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.00013	0.000364	CcSEcCtD
Octreotide—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.00013	0.000364	CcSEcCtD
Octreotide—Oedema—Betamethasone—systemic lupus erythematosus	0.00013	0.000364	CcSEcCtD
Octreotide—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000129	0.000362	CcSEcCtD
Octreotide—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000129	0.000362	CcSEcCtD
Octreotide—Infection—Dexamethasone—systemic lupus erythematosus	0.000129	0.000361	CcSEcCtD
Octreotide—Infection—Betamethasone—systemic lupus erythematosus	0.000129	0.000361	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000128	0.000853	CbGpPWpGaD
Octreotide—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000128	0.00036	CcSEcCtD
Octreotide—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000128	0.00036	CcSEcCtD
Octreotide—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000128	0.000359	CcSEcCtD
Octreotide—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000128	0.000359	CcSEcCtD
Octreotide—Visual impairment—Methotrexate—systemic lupus erythematosus	0.000128	0.000359	CcSEcCtD
Octreotide—Anaemia—Prednisone—systemic lupus erythematosus	0.000128	0.000359	CcSEcCtD
Octreotide—Shock—Dexamethasone—systemic lupus erythematosus	0.000127	0.000358	CcSEcCtD
Octreotide—Shock—Betamethasone—systemic lupus erythematosus	0.000127	0.000358	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000127	0.000846	CbGpPWpGaD
Octreotide—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000127	0.000357	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000127	0.000845	CbGpPWpGaD
Octreotide—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000127	0.000357	CcSEcCtD
Octreotide—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000127	0.000357	CcSEcCtD
Octreotide—Agitation—Prednisone—systemic lupus erythematosus	0.000127	0.000356	CcSEcCtD
Octreotide—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000127	0.000356	CcSEcCtD
Octreotide—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000127	0.000356	CcSEcCtD
Octreotide—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000126	0.000355	CcSEcCtD
Octreotide—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000126	0.000355	CcSEcCtD
Octreotide—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000126	0.000353	CcSEcCtD
Octreotide—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000126	0.000353	CcSEcCtD
Octreotide—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000125	0.000352	CcSEcCtD
Octreotide—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000125	0.000351	CcSEcCtD
Octreotide—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000125	0.000351	CcSEcCtD
Octreotide—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000125	0.000351	CcSEcCtD
Octreotide—Malaise—Prednisone—systemic lupus erythematosus	0.000125	0.00035	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.000124	0.000826	CbGpPWpGaD
Octreotide—Vertigo—Prednisone—systemic lupus erythematosus	0.000124	0.000349	CcSEcCtD
Octreotide—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000124	0.000348	CcSEcCtD
Octreotide—Syncope—Prednisone—systemic lupus erythematosus	0.000124	0.000348	CcSEcCtD
Octreotide—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000124	0.000347	CcSEcCtD
Octreotide—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000124	0.000347	CcSEcCtD
Octreotide—Anorexia—Betamethasone—systemic lupus erythematosus	0.000124	0.000347	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—PRL—systemic lupus erythematosus	0.000123	0.00082	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000123	0.00082	CbGpPWpGaD
Octreotide—Urticaria—Prednisolone—systemic lupus erythematosus	0.000123	0.000346	CcSEcCtD
Octreotide—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000123	0.000346	CcSEcCtD
Octreotide—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000123	0.000345	CcSEcCtD
Octreotide—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000123	0.000345	CcSEcCtD
Octreotide—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000123	0.000344	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.000122	0.000814	CbGpPWpGaD
Octreotide—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000122	0.000344	CcSEcCtD
Octreotide—Pain—Triamcinolone—systemic lupus erythematosus	0.000122	0.000343	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000122	0.000811	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000122	0.000808	CbGpPWpGaD
Octreotide—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000122	0.000341	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—C3—systemic lupus erythematosus	0.000121	0.000807	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000121	0.000805	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000121	0.000802	CbGpPWpGaD
Octreotide—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000121	0.000339	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—C3—systemic lupus erythematosus	0.000121	0.000801	CbGpPWpGaD
Octreotide—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.00012	0.000338	CcSEcCtD
Octreotide—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.00012	0.000336	CcSEcCtD
Octreotide—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.00012	0.000336	CcSEcCtD
Octreotide—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.00012	0.000336	CcSEcCtD
Octreotide—Convulsion—Prednisone—systemic lupus erythematosus	0.00012	0.000336	CcSEcCtD
Octreotide—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000119	0.000335	CcSEcCtD
Octreotide—Hypertension—Prednisone—systemic lupus erythematosus	0.000119	0.000335	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—PRL—systemic lupus erythematosus	0.000118	0.000786	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000118	0.000331	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000118	0.000331	CcSEcCtD
Octreotide—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.00033	CcSEcCtD
Octreotide—Arthralgia—Prednisone—systemic lupus erythematosus	0.000118	0.00033	CcSEcCtD
Octreotide—Myalgia—Prednisone—systemic lupus erythematosus	0.000118	0.00033	CcSEcCtD
Octreotide—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000118	0.00033	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—F2—systemic lupus erythematosus	0.000117	0.00078	CbGpPWpGaD
Octreotide—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000117	0.000329	CcSEcCtD
Octreotide—Anxiety—Prednisone—systemic lupus erythematosus	0.000117	0.000329	CcSEcCtD
Octreotide—Alopecia—Methotrexate—systemic lupus erythematosus	0.000117	0.000329	CcSEcCtD
Octreotide—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000117	0.000329	CcSEcCtD
Octreotide—Insomnia—Betamethasone—systemic lupus erythematosus	0.000117	0.000329	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000117	0.000328	CcSEcCtD
Octreotide—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000117	0.000328	CcSEcCtD
Octreotide—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000117	0.000327	CcSEcCtD
Octreotide—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000116	0.000326	CcSEcCtD
Octreotide—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000116	0.000326	CcSEcCtD
Octreotide—Discomfort—Prednisone—systemic lupus erythematosus	0.000116	0.000326	CcSEcCtD
Octreotide—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000116	0.000326	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000116	0.000771	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000116	0.000771	CbGpPWpGaD
Octreotide—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000116	0.000324	CcSEcCtD
Octreotide—Erythema—Methotrexate—systemic lupus erythematosus	0.000116	0.000324	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—F2—systemic lupus erythematosus	0.000116	0.000768	CbGpPWpGaD
Octreotide—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000114	0.000321	CcSEcCtD
Octreotide—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000114	0.00032	CcSEcCtD
Octreotide—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000114	0.00032	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000114	0.000757	CbGpPWpGaD
Octreotide—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000114	0.00032	CcSEcCtD
Octreotide—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000113	0.000318	CcSEcCtD
Octreotide—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000113	0.000318	CcSEcCtD
Octreotide—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000113	0.000317	CcSEcCtD
Octreotide—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000113	0.000317	CcSEcCtD
Octreotide—Oedema—Prednisone—systemic lupus erythematosus	0.000113	0.000317	CcSEcCtD
Octreotide—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000113	0.000317	CcSEcCtD
Octreotide—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000113	0.000316	CcSEcCtD
Octreotide—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000113	0.000316	CcSEcCtD
Octreotide—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000113	0.000316	CcSEcCtD
Octreotide—Infection—Prednisone—systemic lupus erythematosus	0.000112	0.000315	CcSEcCtD
Octreotide—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000112	0.000314	CcSEcCtD
Octreotide—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000112	0.000314	CcSEcCtD
Octreotide—Back pain—Methotrexate—systemic lupus erythematosus	0.000112	0.000314	CcSEcCtD
Octreotide—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000112	0.000314	CcSEcCtD
Octreotide—Fatigue—Betamethasone—systemic lupus erythematosus	0.000112	0.000313	CcSEcCtD
Octreotide—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000112	0.000313	CcSEcCtD
Octreotide—Shock—Prednisone—systemic lupus erythematosus	0.000111	0.000311	CcSEcCtD
Octreotide—Pain—Betamethasone—systemic lupus erythematosus	0.000111	0.000311	CcSEcCtD
Octreotide—Pain—Dexamethasone—systemic lupus erythematosus	0.000111	0.000311	CcSEcCtD
Octreotide—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000111	0.00031	CcSEcCtD
Octreotide—Tachycardia—Prednisone—systemic lupus erythematosus	0.00011	0.000309	CcSEcCtD
Octreotide—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.00011	0.000309	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.00011	0.000731	CbGpPWpGaD
Octreotide—Skin disorder—Prednisone—systemic lupus erythematosus	0.00011	0.000308	CcSEcCtD
Octreotide—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000109	0.000306	CcSEcCtD
Octreotide—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000109	0.000306	CcSEcCtD
Octreotide—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000109	0.000305	CcSEcCtD
Octreotide—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000108	0.000304	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.000108	0.000719	CbGpPWpGaD
Octreotide—Rash—Cyclosporine—systemic lupus erythematosus	0.000108	0.000302	CcSEcCtD
Octreotide—Anorexia—Prednisone—systemic lupus erythematosus	0.000108	0.000302	CcSEcCtD
Octreotide—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000107	0.000302	CcSEcCtD
Octreotide—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000107	0.000301	CcSEcCtD
Octreotide—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000107	0.000301	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.000107	0.000712	CbGpPWpGaD
Octreotide—Headache—Cyclosporine—systemic lupus erythematosus	0.000107	0.0003	CcSEcCtD
Octreotide—Anaemia—Methotrexate—systemic lupus erythematosus	0.000107	0.0003	CcSEcCtD
Octreotide—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000107	0.0003	CcSEcCtD
Octreotide—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000107	0.0003	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—F2—systemic lupus erythematosus	0.000107	0.000708	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000106	0.000297	CcSEcCtD
Octreotide—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000106	0.000297	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—F2—systemic lupus erythematosus	0.000106	0.000704	CbGpPWpGaD
Octreotide—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000106	0.000297	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000105	0.0007	CbGpPWpGaD
Octreotide—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000105	0.000295	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—JUNB—systemic lupus erythematosus	0.000105	0.000699	CbGpPWpGaD
Octreotide—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000105	0.000295	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—PRL—systemic lupus erythematosus	0.000105	0.000697	CbGpPWpGaD
Octreotide—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000105	0.000294	CcSEcCtD
Octreotide—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000105	0.000294	CcSEcCtD
Octreotide—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000104	0.000293	CcSEcCtD
Octreotide—Malaise—Methotrexate—systemic lupus erythematosus	0.000104	0.000292	CcSEcCtD
Octreotide—Vertigo—Methotrexate—systemic lupus erythematosus	0.000104	0.000291	CcSEcCtD
Octreotide—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000104	0.000291	CcSEcCtD
Octreotide—SSTR5—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.000103	0.000684	CbGpPWpGaD
Octreotide—Urticaria—Betamethasone—systemic lupus erythematosus	0.000103	0.000289	CcSEcCtD
Octreotide—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000103	0.000289	CcSEcCtD
Octreotide—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000103	0.000288	CcSEcCtD
Octreotide—Dizziness—Prednisolone—systemic lupus erythematosus	0.000103	0.000288	CcSEcCtD
Octreotide—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000102	0.000287	CcSEcCtD
Octreotide—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000102	0.000287	CcSEcCtD
Octreotide—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000102	0.000287	CcSEcCtD
Octreotide—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000102	0.000287	CcSEcCtD
Octreotide—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000102	0.000287	CcSEcCtD
Octreotide—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000102	0.000287	CcSEcCtD
Octreotide—Insomnia—Prednisone—systemic lupus erythematosus	0.000102	0.000286	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CD80—systemic lupus erythematosus	0.000102	0.000675	CbGpPWpGaD
Octreotide—Nausea—Cyclosporine—systemic lupus erythematosus	0.000101	0.000284	CcSEcCtD
Octreotide—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000101	0.000284	CcSEcCtD
Octreotide—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000101	0.000283	CcSEcCtD
Octreotide—Cough—Methotrexate—systemic lupus erythematosus	0.000101	0.000283	CcSEcCtD
Octreotide—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000101	0.000283	CcSEcCtD
Octreotide—SSTR3—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000101	0.000669	CbGpPWpGaD
Octreotide—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.0001	0.000281	CcSEcCtD
Octreotide—Convulsion—Methotrexate—systemic lupus erythematosus	0.0001	0.000281	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	9.99e-05	0.000664	CbGpPWpGaD
Octreotide—Dyspepsia—Prednisone—systemic lupus erythematosus	9.93e-05	0.000279	CcSEcCtD
Octreotide—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	9.89e-05	0.000277	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—JAK1—systemic lupus erythematosus	9.87e-05	0.000656	CbGpPWpGaD
Octreotide—Chest pain—Methotrexate—systemic lupus erythematosus	9.84e-05	0.000276	CcSEcCtD
Octreotide—Myalgia—Methotrexate—systemic lupus erythematosus	9.84e-05	0.000276	CcSEcCtD
Octreotide—Arthralgia—Methotrexate—systemic lupus erythematosus	9.84e-05	0.000276	CcSEcCtD
Octreotide—Decreased appetite—Prednisone—systemic lupus erythematosus	9.81e-05	0.000275	CcSEcCtD
Octreotide—Rash—Prednisolone—systemic lupus erythematosus	9.79e-05	0.000275	CcSEcCtD
Octreotide—Dermatitis—Prednisolone—systemic lupus erythematosus	9.78e-05	0.000274	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	9.77e-05	0.000274	CcSEcCtD
Octreotide—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	9.75e-05	0.000274	CcSEcCtD
Octreotide—Fatigue—Prednisone—systemic lupus erythematosus	9.73e-05	0.000273	CcSEcCtD
Octreotide—Headache—Prednisolone—systemic lupus erythematosus	9.73e-05	0.000273	CcSEcCtD
Octreotide—Discomfort—Methotrexate—systemic lupus erythematosus	9.72e-05	0.000273	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—PRL—systemic lupus erythematosus	9.69e-05	0.000644	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—IL2—systemic lupus erythematosus	9.66e-05	0.000642	CbGpPWpGaD
Octreotide—Constipation—Prednisone—systemic lupus erythematosus	9.65e-05	0.000271	CcSEcCtD
Octreotide—Vomiting—Hydrocortisone—systemic lupus erythematosus	9.64e-05	0.000271	CcSEcCtD
Octreotide—Rash—Hydrocortisone—systemic lupus erythematosus	9.56e-05	0.000268	CcSEcCtD
Octreotide—Dermatitis—Hydrocortisone—systemic lupus erythematosus	9.55e-05	0.000268	CcSEcCtD
Octreotide—SSTR2—Signaling by GPCR—CCL2—systemic lupus erythematosus	9.5e-05	0.000631	CbGpPWpGaD
Octreotide—Headache—Hydrocortisone—systemic lupus erythematosus	9.5e-05	0.000267	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—JAK1—systemic lupus erythematosus	9.47e-05	0.000629	CbGpPWpGaD
Octreotide—Dizziness—Triamcinolone—systemic lupus erythematosus	9.44e-05	0.000265	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—CCL2—systemic lupus erythematosus	9.44e-05	0.000627	CbGpPWpGaD
Octreotide—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	9.43e-05	0.000265	CcSEcCtD
Octreotide—Dizziness—Methylprednisolone—systemic lupus erythematosus	9.42e-05	0.000264	CcSEcCtD
Octreotide—Infection—Methotrexate—systemic lupus erythematosus	9.37e-05	0.000263	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CCR5—systemic lupus erythematosus	9.36e-05	0.000622	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—TYK2—systemic lupus erythematosus	9.35e-05	0.000621	CbGpPWpGaD
Octreotide—Feeling abnormal—Prednisone—systemic lupus erythematosus	9.3e-05	0.000261	CcSEcCtD
Octreotide—Asthenia—Dexamethasone—systemic lupus erythematosus	9.3e-05	0.000261	CcSEcCtD
Octreotide—Asthenia—Betamethasone—systemic lupus erythematosus	9.3e-05	0.000261	CcSEcCtD
Octreotide—Nervous system disorder—Methotrexate—systemic lupus erythematosus	9.25e-05	0.000259	CcSEcCtD
Octreotide—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	9.23e-05	0.000259	CcSEcCtD
Octreotide—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	9.23e-05	0.000259	CcSEcCtD
Octreotide—Nausea—Prednisolone—systemic lupus erythematosus	9.22e-05	0.000259	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—IL2RA—systemic lupus erythematosus	9.22e-05	0.000613	CbGpPWpGaD
Octreotide—Pruritus—Betamethasone—systemic lupus erythematosus	9.17e-05	0.000257	CcSEcCtD
Octreotide—Pruritus—Dexamethasone—systemic lupus erythematosus	9.17e-05	0.000257	CcSEcCtD
Octreotide—Skin disorder—Methotrexate—systemic lupus erythematosus	9.16e-05	0.000257	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—IL2—systemic lupus erythematosus	9.15e-05	0.000608	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—C3—systemic lupus erythematosus	9.14e-05	0.000607	CbGpPWpGaD
Octreotide—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	9.12e-05	0.000256	CcSEcCtD
Octreotide—Vomiting—Triamcinolone—systemic lupus erythematosus	9.08e-05	0.000255	CcSEcCtD
Octreotide—Vomiting—Methylprednisolone—systemic lupus erythematosus	9.06e-05	0.000254	CcSEcCtD
Octreotide—Nausea—Hydrocortisone—systemic lupus erythematosus	9.01e-05	0.000253	CcSEcCtD
Octreotide—Rash—Triamcinolone—systemic lupus erythematosus	9e-05	0.000253	CcSEcCtD
Octreotide—Dermatitis—Triamcinolone—systemic lupus erythematosus	9e-05	0.000252	CcSEcCtD
Octreotide—Anorexia—Methotrexate—systemic lupus erythematosus	8.99e-05	0.000252	CcSEcCtD
Octreotide—Rash—Methylprednisolone—systemic lupus erythematosus	8.98e-05	0.000252	CcSEcCtD
Octreotide—Dermatitis—Methylprednisolone—systemic lupus erythematosus	8.98e-05	0.000252	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CCR5—systemic lupus erythematosus	8.97e-05	0.000596	CbGpPWpGaD
Octreotide—Urticaria—Prednisone—systemic lupus erythematosus	8.96e-05	0.000252	CcSEcCtD
Octreotide—Headache—Triamcinolone—systemic lupus erythematosus	8.95e-05	0.000251	CcSEcCtD
Octreotide—Headache—Methylprednisolone—systemic lupus erythematosus	8.93e-05	0.00025	CcSEcCtD
Octreotide—Body temperature increased—Prednisone—systemic lupus erythematosus	8.92e-05	0.00025	CcSEcCtD
Octreotide—Abdominal pain—Prednisone—systemic lupus erythematosus	8.92e-05	0.00025	CcSEcCtD
Octreotide—Diarrhoea—Dexamethasone—systemic lupus erythematosus	8.87e-05	0.000249	CcSEcCtD
Octreotide—Diarrhoea—Betamethasone—systemic lupus erythematosus	8.87e-05	0.000249	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	8.84e-05	0.000587	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL2—systemic lupus erythematosus	8.77e-05	0.000583	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—C3—systemic lupus erythematosus	8.77e-05	0.000582	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—TYK2—systemic lupus erythematosus	8.63e-05	0.000573	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	8.59e-05	0.000241	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—TYK2—systemic lupus erythematosus	8.57e-05	0.00057	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—IL2—systemic lupus erythematosus	8.57e-05	0.000569	CbGpPWpGaD
Octreotide—Dizziness—Dexamethasone—systemic lupus erythematosus	8.57e-05	0.00024	CcSEcCtD
Octreotide—Dizziness—Betamethasone—systemic lupus erythematosus	8.57e-05	0.00024	CcSEcCtD
Octreotide—Insomnia—Methotrexate—systemic lupus erythematosus	8.53e-05	0.000239	CcSEcCtD
Octreotide—Nausea—Triamcinolone—systemic lupus erythematosus	8.48e-05	0.000238	CcSEcCtD
Octreotide—Paraesthesia—Methotrexate—systemic lupus erythematosus	8.47e-05	0.000238	CcSEcCtD
Octreotide—Nausea—Methylprednisolone—systemic lupus erythematosus	8.46e-05	0.000237	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—NOS3—systemic lupus erythematosus	8.41e-05	0.000559	CbGpPWpGaD
Octreotide—Dyspnoea—Methotrexate—systemic lupus erythematosus	8.41e-05	0.000236	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—JAK1—systemic lupus erythematosus	8.4e-05	0.000558	CbGpPWpGaD
Octreotide—Somnolence—Methotrexate—systemic lupus erythematosus	8.38e-05	0.000235	CcSEcCtD
Octreotide—Hypersensitivity—Prednisone—systemic lupus erythematosus	8.31e-05	0.000233	CcSEcCtD
Octreotide—Dyspepsia—Methotrexate—systemic lupus erythematosus	8.3e-05	0.000233	CcSEcCtD
Octreotide—Vomiting—Dexamethasone—systemic lupus erythematosus	8.24e-05	0.000231	CcSEcCtD
Octreotide—Vomiting—Betamethasone—systemic lupus erythematosus	8.24e-05	0.000231	CcSEcCtD
Octreotide—Decreased appetite—Methotrexate—systemic lupus erythematosus	8.2e-05	0.00023	CcSEcCtD
Octreotide—Rash—Betamethasone—systemic lupus erythematosus	8.17e-05	0.000229	CcSEcCtD
Octreotide—Rash—Dexamethasone—systemic lupus erythematosus	8.17e-05	0.000229	CcSEcCtD
Octreotide—Dermatitis—Betamethasone—systemic lupus erythematosus	8.16e-05	0.000229	CcSEcCtD
Octreotide—Dermatitis—Dexamethasone—systemic lupus erythematosus	8.16e-05	0.000229	CcSEcCtD
Octreotide—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	8.14e-05	0.000228	CcSEcCtD
Octreotide—Fatigue—Methotrexate—systemic lupus erythematosus	8.13e-05	0.000228	CcSEcCtD
Octreotide—Headache—Dexamethasone—systemic lupus erythematosus	8.12e-05	0.000228	CcSEcCtD
Octreotide—Headache—Betamethasone—systemic lupus erythematosus	8.12e-05	0.000228	CcSEcCtD
Octreotide—Asthenia—Prednisone—systemic lupus erythematosus	8.1e-05	0.000227	CcSEcCtD
Octreotide—Pain—Methotrexate—systemic lupus erythematosus	8.06e-05	0.000226	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—F2—systemic lupus erythematosus	8.03e-05	0.000533	CbGpPWpGaD
Octreotide—Pruritus—Prednisone—systemic lupus erythematosus	7.98e-05	0.000224	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CCR5—systemic lupus erythematosus	7.96e-05	0.000529	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—IL2—systemic lupus erythematosus	7.91e-05	0.000525	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.84e-05	0.000521	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL2—systemic lupus erythematosus	7.78e-05	0.000517	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—C3—systemic lupus erythematosus	7.77e-05	0.000516	CbGpPWpGaD
Octreotide—Feeling abnormal—Methotrexate—systemic lupus erythematosus	7.77e-05	0.000218	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—JAK1—systemic lupus erythematosus	7.75e-05	0.000515	CbGpPWpGaD
Octreotide—Diarrhoea—Prednisone—systemic lupus erythematosus	7.72e-05	0.000217	CcSEcCtD
Octreotide—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	7.71e-05	0.000216	CcSEcCtD
Octreotide—Nausea—Dexamethasone—systemic lupus erythematosus	7.7e-05	0.000216	CcSEcCtD
Octreotide—Nausea—Betamethasone—systemic lupus erythematosus	7.7e-05	0.000216	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—F2—systemic lupus erythematosus	7.7e-05	0.000511	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CD80—systemic lupus erythematosus	7.7e-05	0.000511	CbGpPWpGaD
Octreotide—Urticaria—Methotrexate—systemic lupus erythematosus	7.49e-05	0.00021	CcSEcCtD
Octreotide—Dizziness—Prednisone—systemic lupus erythematosus	7.46e-05	0.000209	CcSEcCtD
Octreotide—Body temperature increased—Methotrexate—systemic lupus erythematosus	7.45e-05	0.000209	CcSEcCtD
Octreotide—Abdominal pain—Methotrexate—systemic lupus erythematosus	7.45e-05	0.000209	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CD80—systemic lupus erythematosus	7.38e-05	0.00049	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CCR5—systemic lupus erythematosus	7.34e-05	0.000488	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.29e-05	0.000484	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.24e-05	0.000481	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL2—systemic lupus erythematosus	7.18e-05	0.000477	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—C3—systemic lupus erythematosus	7.17e-05	0.000477	CbGpPWpGaD
Octreotide—Vomiting—Prednisone—systemic lupus erythematosus	7.17e-05	0.000201	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—CCL2—systemic lupus erythematosus	7.15e-05	0.000475	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL2—systemic lupus erythematosus	7.13e-05	0.000474	CbGpPWpGaD
Octreotide—Rash—Prednisone—systemic lupus erythematosus	7.11e-05	0.0002	CcSEcCtD
Octreotide—Dermatitis—Prednisone—systemic lupus erythematosus	7.11e-05	0.000199	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—IL6—systemic lupus erythematosus	7.1e-05	0.000472	CbGpPWpGaD
Octreotide—Headache—Prednisone—systemic lupus erythematosus	7.07e-05	0.000198	CcSEcCtD
Octreotide—Hypersensitivity—Methotrexate—systemic lupus erythematosus	6.95e-05	0.000195	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—CCL2—systemic lupus erythematosus	6.86e-05	0.000456	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—F2—systemic lupus erythematosus	6.83e-05	0.000453	CbGpPWpGaD
Octreotide—Asthenia—Methotrexate—systemic lupus erythematosus	6.77e-05	0.00019	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—MMP9—systemic lupus erythematosus	6.75e-05	0.000448	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.73e-05	0.000447	CbGpPWpGaD
Octreotide—Nausea—Prednisone—systemic lupus erythematosus	6.7e-05	0.000188	CcSEcCtD
Octreotide—Pruritus—Methotrexate—systemic lupus erythematosus	6.67e-05	0.000187	CcSEcCtD
Octreotide—SSTR5—Signaling Pathways—CD80—systemic lupus erythematosus	6.54e-05	0.000435	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TYK2—systemic lupus erythematosus	6.5e-05	0.000432	CbGpPWpGaD
Octreotide—Diarrhoea—Methotrexate—systemic lupus erythematosus	6.45e-05	0.000181	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—EP300—systemic lupus erythematosus	6.4e-05	0.000425	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—NOS3—systemic lupus erythematosus	6.38e-05	0.000424	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—F2—systemic lupus erythematosus	6.3e-05	0.000418	CbGpPWpGaD
Octreotide—Dizziness—Methotrexate—systemic lupus erythematosus	6.24e-05	0.000175	CcSEcCtD
Octreotide—SSTR1—Signaling Pathways—TYK2—systemic lupus erythematosus	6.23e-05	0.000414	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—NOS3—systemic lupus erythematosus	6.11e-05	0.000406	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CCL2—systemic lupus erythematosus	6.08e-05	0.000404	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—VEGFA—systemic lupus erythematosus	6.06e-05	0.000403	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CD80—systemic lupus erythematosus	6.04e-05	0.000401	CbGpPWpGaD
Octreotide—Vomiting—Methotrexate—systemic lupus erythematosus	6e-05	0.000168	CcSEcCtD
Octreotide—Rash—Methotrexate—systemic lupus erythematosus	5.95e-05	0.000167	CcSEcCtD
Octreotide—Dermatitis—Methotrexate—systemic lupus erythematosus	5.94e-05	0.000167	CcSEcCtD
Octreotide—Headache—Methotrexate—systemic lupus erythematosus	5.91e-05	0.000166	CcSEcCtD
Octreotide—SSTR2—Signaling Pathways—CCL2—systemic lupus erythematosus	5.61e-05	0.000373	CbGpPWpGaD
Octreotide—Nausea—Methotrexate—systemic lupus erythematosus	5.6e-05	0.000157	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.56e-05	0.00037	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TYK2—systemic lupus erythematosus	5.52e-05	0.000367	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.52e-05	0.000367	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—NOS3—systemic lupus erythematosus	5.42e-05	0.00036	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL2—systemic lupus erythematosus	5.41e-05	0.000359	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—IL6—systemic lupus erythematosus	5.38e-05	0.000357	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.3e-05	0.000352	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL2—systemic lupus erythematosus	5.18e-05	0.000344	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—IL6—systemic lupus erythematosus	5.16e-05	0.000343	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—systemic lupus erythematosus	5.12e-05	0.00034	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TYK2—systemic lupus erythematosus	5.1e-05	0.000339	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.1e-05	0.000339	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—NOS3—systemic lupus erythematosus	5e-05	0.000332	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—systemic lupus erythematosus	4.91e-05	0.000326	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.89e-05	0.000325	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EP300—systemic lupus erythematosus	4.85e-05	0.000322	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.7e-05	0.000312	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EP300—systemic lupus erythematosus	4.65e-05	0.000309	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL2—systemic lupus erythematosus	4.6e-05	0.000305	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.59e-05	0.000305	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—IL6—systemic lupus erythematosus	4.57e-05	0.000304	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.4e-05	0.000293	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—systemic lupus erythematosus	4.35e-05	0.000289	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.33e-05	0.000288	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.33e-05	0.000288	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL2—systemic lupus erythematosus	4.24e-05	0.000282	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—IL6—systemic lupus erythematosus	4.22e-05	0.00028	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.22e-05	0.00028	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—IL6—systemic lupus erythematosus	4.19e-05	0.000279	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EP300—systemic lupus erythematosus	4.12e-05	0.000274	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.04e-05	0.000269	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—systemic lupus erythematosus	4.01e-05	0.000267	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4e-05	0.000266	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.91e-05	0.00026	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EP300—systemic lupus erythematosus	3.81e-05	0.000253	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.61e-05	0.000239	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.59e-05	0.000238	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.31e-05	0.00022	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—IL6—systemic lupus erythematosus	3.18e-05	0.000211	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—IL6—systemic lupus erythematosus	3.05e-05	0.000202	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—IL6—systemic lupus erythematosus	2.7e-05	0.000179	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—IL6—systemic lupus erythematosus	2.49e-05	0.000166	CbGpPWpGaD
